CSIMarket
 

Nutra Pharma Corp   (NPHC)

Nutra Pharma 's

Competitiveness




 

NPHC Sales vs. its Competitors Q2 2026







Revenue Growth Comparisons




Net Income Comparison




<<  NPHC Stock Performance Comparisons


Nutra Pharma 's Comment on Competition and Industry Peers


The company operates in the biotechnology research and development sector, which is characterized by intense competition and rapid change. Competitors, both domestic and international, possess significantly greater financial, scientific, and human resources, enabling more advanced research, product development, and revenue generation. To address this competitive landscape, the company intends to establish strategic partnerships or alliances with pharmaceutical companies, academic institutions, biotechnology firms, and clinical diagnostic laboratories. Key competitors in the biologics field include Amgen, Sanofi-Aventis, Biogen-Idec, Cephalon, Genentech, Genzyme, Novartis, Regeneron, Roche, and Bayer, all of which have substantially superior financial, technological, and operational capabilities. Competition is particularly strong among companies developing and marketing products based on advanced cellular and molecular biology.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Nutra Pharma Corp



Sources: Nutra Pharma Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nutra Pharma Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.